Screening for Cognitive Dysfunction in Systemic Lupus Erythematosus: a Systematic Review
DOI:
https://doi.org/10.13129/2282-1619/mjcp-5117Keywords:
Cognitive dysfunction, systemic lupus erythematosus, Screening, Clinical neuropsychologyAbstract
Background: Screening instruments are brief and simple tools designed to identify alterations in cognitive functioning, as well as to rule out or confirm the presence of cognitive dysfunction. Systemic lupus erythematosus (SLE) is an inflammatory disease that affects multiple organs of the human body, including the nervous system, which can cause neuropsychiatric symptoms such as cognitive dysfunction. Objective: To analyze the scientific evidence on cognitive screening tests used in SLE and the cutoff points suggested in academic literature.
Methodology: A systematic review was conducted from 2014 to the second half of 2024, in databases such as PubMed, Scopus, Web of Science, ScienceDirect, Redalyc and SciELO, based on combinations of keywords and Boolean operators: "cognitive dysfunction", "cognitive impairment", "cognitive decline", "lupus", "systemic lupus erythematosus", "SLE", "Montreal Cognitive Assessment", "MoCA", “MMSE”, “Mini-Mental State Examination”, “INECO Frontal Screening", "INECO", "Addenbrooke's Cognitive Examination", and "ACE-R III".
Results: The search yielded a total of 564 works, of which 31 documents met the inclusion criteria and were analyzed. The results show that the MoCA is the preferred tool by physicians and specialists worldwide for cognitive screening in patients with SLE, both in patients with and without clear neuropsychiatric symptoms.
Conclusion: The literature consistently supports a cutoff score of <26 on the MoCA as the most widely used threshold for identifying cognitive dysfunction in individuals with systemic lupus erythematosus, with this criterion receiving the strongest empirical validation across published studies. However, some studies have explored lower cutoff scores to improve the instrument's specificity and sensitivity, especially in the SLE population.
References
Acosta, R., Dorado, C., & Utria, O. (2014). Inclusión de la neuropsicología como servicio especializado de salud en Colombia. Psychologia, 8(2), 97–106. https://doi.org/10.21500/19002386.1224
American College of Rheumatology-ACR-. (1999). The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis and Rheumatism, 42(4), 599–608. https://doi.org/10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
Adhikari, T., Piatti, A., & Luggen, M. (2011). Cognitive dysfunction in SLE: development of a screening tool. Lupus, 20(11), 1142–1146. https://doi.org/10.1177/0961203311405374
Ahmadzade, A., Simani, L., Roozbeh, M., Farsad, F., Sheibani, M., Negaresh, O., Emam, M. M., Rajaei, A., Kazempour, M., Ramezani, M., & Nazarpoor, S. (2024). Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus. Caspian Journal of Internal Medicine, 15(1), 58–65. https://doi.org/10.22088/cjim.15.1.6
Antonchak, M. A., Saoudian, M., Khan, A. R., Brunner, H. I., & Luggen, M. E. (2011). Cognitive dysfunction in patients with systemic lupus erythematosus: a controlled study. The Journal of Rheumatology, 38(6), 1020–1025. https://doi.org/10.3899/jrheum.100560
Barraclough, M., McKie, S., Parker, B., Elliott, R., & Bruce, I. N. (2021). The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus. Rheumatology (Oxford, England), 61(1), 195–204. https://doi.org/10.1093/rheumatology/keab256
Bizzo, B. C., Sanchez, T. A., Tukamoto, G., Zimmermann, N., Netto, T. M., & Gasparetto, E. L. (2017). Cortical Thickness and episodic memory impairment in systemic lupus erythematosus. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging, 27(1), 122–127. https://doi.org/10.1111/jon.12394
Borba, E. A., Scoto Dias, E., Tercziany Vanzin, J. H., Ferreira de Queiroz Junior, N., Dos Santos, T. A. F., Skare, T., & Nisihara, R. (2023). Cognitive dysfunction in patients with systemic lupus erythematosus. A cross-sectional study in a Brazilian sample. Lupus, 32(7), 900–909. https://doi.org/10.1177/09612033231176794
Bruno, D., Slachevsky, A., Fiorentino, N., Rueda, D. S., Bruno, G., Tagle, A. R., Olavarria, L., Flores, P., Lillo, P., Roca, M., & Torralva, T. (2020). Validación argentino-chilena de la versión en español del test Addenbrooke's Cognitive Examination III para el diagnóstico de demencia. Neurología, 35(2), 82–88. https://doi.org/10.1016/j.nrl.2017.06.004
Butt, B. A., Farman, S., Khan, S. E., Saeed, M. A., & Ahmad, N. M. (2017). Cognitive dysfunction in patients with Systemic Lupus Erythematosus. Pakistan Journal of Medical Sciences, 33(1), 59–64. https://doi.org/10.12669/pjms.331.11947
Button, B., Catalá-Lopez, F., & Moher, D. (2016). La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA. Revista de Medicina Clínica, 147(6), 262-266. https://doi.org/10.1016/j.medcli.2016.02.025
Calderón, J., Flores, P., Aguirre, J. M., Valdivia, G., Padilla, O., Barra, I., Scoriels, L., Herrera, S., González, A., & Massardo, L. (2017). Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus. Scandinavian Journal of Rheumatology, 46(4), 273–280. https://doi.org/10.1080/03009742.2016.1206617
Ceccarelli, F., Perricone, C., Pirone, C., Massaro, L., Alessandri, C., Mina, C., Marianetti, M., Spinelli, F. R., Valesini, G., & Conti, F. (2018). Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study. PloS one, 13(5), e0196103. https://doi.org/10.1371/journal.pone.0196103
Chalhoub, N. E., & Luggen, M. E. (2019). Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly. Lupus, 28(1), 51–58. https://doi.org/10.1177/0961203318815299
Delgado Reyes, A., & Sanchez Lopez, J. (2021) Escenarios virtuales para la evaluación neuropsicologica: una revisión de tema. Cuadernos de Neuropsicología / Panamerican Journal of Neuropsychology. 15 (2), 196-213. https://doi.org/10.7714/CNPS/15.2.216
Elsisi, G. H., Quintana, G., Gil, D., Santos, P., & Fernandez, D. (2024). Clinical and economic burden of systemic lupus erythematosus in Colombia. Journal of Medical Economics, 27(sup1), 1–11. https://doi.org/10.1080/13696998.2024.2316536
El-Shafey, A. M., Abd-El-Geleel, S. M., & Soliman, E. S. (2012). Cognitive impairment in non-neuropsychiatric systemic lupus erythematosus. The Egyptian Rheumatologist, 34(2), 67–73. https://doi.org/10.1016/j.ejr.2012.02.002
Fernández-Ávila, D. G., Bernal-Macías, S., Rincón-Riaño, D. N., Gutiérrez Dávila, J. M., & Rosselli, D. (2019). Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012-2016. Lupus, 28(10), 1273–1278. https://doi.org/10.1177/0961203319864168
Folstein, M., Folstein, S., & McHugh, P. (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6
Frazzei, G., van Vollenhoven, R. F., de Jong, B. A., Siegelaar, S. E., & van Schaardenburg, D. (2022). Preclinical autoimmune disease: a Comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and Type 1 Diabetes. Frontiers in Immunology, 13, 899372. https://doi.org/10.3389/fimmu.2022.899372
Freitas, S., Simões, M. R., Alves, L., Duro, D., & Santana, I. (2012). Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia. Journal of Geriatric Psychiatry and Neurology, 25(3), 146–154. https://doi.org/10.1177/0891988712455235
García-García, J., Arcaya, J., Vicente, J., & Lantada, N. (1999) Una propuesta de aplicación y puntuación del test del reloj en la enfermedad de Alzheimer. Rev. Neurol. 28 (7): 648-655. http://neurologia.publicacionmedica.com/contenido/images/Una_propuesta_de_aplicación_y_puntuación_del_test_del.pdf
Galimberti, C., Bosi, M. F., Caricasole, V., Zanello, R., Dell'Osso, B., & Viganò, C. A. (2020). Using network analysis to explore cognitive domains in patients with unipolar versus bipolar depression: a prospective naturalistic study. CNS spectrums, 25(3), 380–391. https://doi.org/10.1017/S1092852919000968
Grover, S., Sahoo, S., Naskar, C., & Sharma, A. (2023). Psychiatric comorbidities in patients suffering from systemic lupus erythematosus admitted to a tertiary care hospital in Northern India. Lupus, 32(8), 1008–1018. https://doi.org/10.1177/09612033231177737
Haddaway, N. R., Page, M. J., Pritchard, C. C., & McGuinness, L. A. (2022). PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis Campbell Systematic Reviews, 18, e1230. https://doi.org/10.1002/cl2.1230
Hanly, J. G., Omisade, A., Su, L., Farewell, V., & Fisk, J. D. (2010). Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. Arthritis y Rheumatism, 62(5), 1478–1486.https://doi.org/10.1002/art.27404
Hanly, J. G., Urowitz, M. B., Su, L., Base, S. C., Gordon, C., Clarke, A., Bernatsky, S., Vasudevan, A., Isenberg, D., Rahman, A., Wallace, D. J., Fortin, P. R., Gladman, D., Romero-Dirz, J., Sanchez-Guerrero, J., Dooley, M. A., Bruce, I., Steinsson, K., Khamashta, M., Manzi, S., … &Merrill, J. T. (2012). Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Annals of Rheumatic Diseases, 70(10), 1726–1732. https://doi.org/10.1136/ard.2010.148502
Hebben, N., & Milberg, W. (2011). Fundamentos para la evaluación neuropsicológica (G. M. Vélez Espinosa, Trad.). Manual Moderno.
Ho, R. C., Husain, S. F. & Ho C. S. (2018) Cognitive dysfunction in patients with systemic lupus erythematosus: The challenge in diagnosis and management. Rheumatology Practice and Research. 3 (1). https://doi.org/10.1177/2059902118792434
Holliday, S. L., Navarrete, M. G., Hermosillo-Romo, D., Valdez, C. R., Saklad, A. R., Escalante, A., & Brey, R. L. (2003). Validating a computerized neuropsychological test battery for mixed ethnic lupus patients. Lupus, 12(9), 697–703. https://doi.org/10.1191/0961203303lu442oa
Hsieh, S., Schubert, S., Hoon, C., Mioshi, E., & Hodges, J. R. (2013). Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 36(3-4), 242–250. https://doi.org/10.1159/000351671
Kammeyer, R., Ogbu, E. A., Cooper, J. C., Stolz, E., Piquet, A. L., Fuhlbrigge, R. C., Bennett, J. L., & Hutaff-Lee, C. (2023). Cognitive dysfunction in pediatric systemic lupus erythematosus: current knowledge and future directions. Child Neuropsychology: a journal on normal and abnormal development in childhood and adolescence, 30(5), 1–29. https://doi.org/10.1080/09297049.2023.2273573
Kanapathy, A., Nik Jaafar, N. R., Shaharir, S. S., Chan, L. F., Rozita, M., & Ch'ng, S. S. (2019). Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia. Lupus, 28(7), 854–861. https://doi.org/10.1177/0961203319852153
Karr, J. E., & Iverson, G. L. (2020). Interpreting high scores on the NIH Toolbox Cognition Battery: Potential utility for detecting cognitive decline in high-functioning individuals. Neuropsychology, 34(7), 764–773. https://doi.org/10.1037/neu0000691
Kim, M. Y., Sen, D., Drummond, R. R., Brandenburg, M. C., Biesanz, K. L., Kim, A. H., Eisen, S. A., Baum, C. M., & Foster, E. R. (2021). Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life. Lupus, 30(7), 1100–1107.https://doi.org/10.1177/09612033211006187
Kivity, S., Agmon-Levin, N., Zandman-Goddard, G., Chapman, J., & Shoenfeld, Y. (2015). Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Medicine, 13, 43. https://doi.org/10.1186/s12916-015-0269-8
Koolvisoot, A., & Chumjang, S. (2023). Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study. Lupus, 32(10), 1199–1210. https://doi.org/10.1177/09612033231196215
Kozora, E., Arciniegas, D. B., Filley, C. M., West, S. G., Brown, M., Miller, D., Grimm, A., Devore, M. D., Wingrove, C., & Zhang, L. (2008). Cognitive and neurologic status in patients with systemic lupus erythematosus without neuropsychiatric syndromes. Arthritis and Rheumatism, 59(11), 1639–1646. https://doi.org/10.1002/art.24189
Kozora, E., Burleson, A. & Filler, C. (2018) Neuropsychological functioning in autoimmune disorders. En: Morgan, J. y Ricker, J. Textbook of clínica Neuropsychology. Routledge Taylor y Francis Group.
Kozora, E., Zell, J. L., Baraghoshi, D., Smith, R. M., & Strand, M. (2022). Improved executive function in patients with systemic lupus erythematosus following interactive digital training. Lupus, 31(8), 910–920. https://doi.org/10.1177/09612033221098534
Langensee, L., Mårtensson, J., Jönsen, A., Zervides, K., Bengtsson, A., Nystedt, J., Cannerfelt, B., Nilsson, P., Mannfolk, P., Lätt, J., Rumetshofer, T., & Sundgren, P. C. (2022). Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study. BMC rheumatology, 6(1), 22. https://doi.org/10.1186/s41927-022-00253-3
Leslie, B., & Crowe, S. F. (2018). Cognitive functioning in systemic lupus erythematosus: a meta-analysis. Lupus, 27(6), 920–929. https://doi.org/10.1177/0961203317751859
Lim, X. R., Chew, P. O. K., Lim, G. H., Low, Y. L., Lim, J. W. P., Ong, H. N., Law, W. G., Tan, J. W. L., Thong, B. Y., Chia, F. L., Lian, T. Y., Chan, G. Y. L., Chan, M. T., Koh, E. T., Kong, K. O., & Howe, H. S. (2022). Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus, 31(14), 1759–1769. https://doi.org/10.1177/09612033221132237
Lu, L., Kong, W., Zhou, K., Chen, J., Hou, Y., Dou, H., & Liang, J. (2021). Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus. BMC Rheumatology, 5(1), 18. https://doi.org/10.1186/s41927-021-00190-7
Maciel, R. O., Ferreira, G. A., Akemy, B., & Cardoso, F. (2016). Executive dysfunction, obsessive-compulsive symptoms, and attention deficit and hyperactivity disorder in Systemic Lupus Erythematosus: Evidence for basal ganglia dysfunction?. Journal of the Neurological Sciences, 360, 94–97. https://doi.org/10.1016/j.jns.2015.11.052
Mahdavi Adeli, A., Haghighi, A., & Malakouti, S. K. (2016). Prevalence of dognitive disorders in patients with systemic lupus erythematosus; a cross-sectional Study in Rasoul-e-Akram Hospital, Tehran, Iran. Archives of Iranian Medicine, 19(4), 257–261. https://pubmed.ncbi.nlm.nih.gov/27041520/
Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613–1620. https://doi.org/10.1212/01.wnl.0000434309.85312.19
Medina, Y. F., Rivera, M. R., Duarte, L. K., Rodriguez-Plata, C. M., De León, E. R., & Rodríguez Martínez, S. C. (2024). Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study. Lupus, 33(10), 1025–1033. https://doi.org/10.1177/09612033241273082
Mendelsohn, S., Khoja, L., Alfred, S., He, J., Anderson, M., DuBois, D., Touma, Z., & Engel, L. (2021). Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review. Lupus, 30(10), 1617–1630. https://doi.org/10.1177/09612033211031008
Meszaros, Z. S., Perl, A., & Faraone, S. V. (2012). Psychiatric symptoms in systemic lupus erythematosus: a systematic review. The Journal of Clinical Psychiatry, 73(7), 993–1001. https://doi.org/10.4088/JCP.11r07425
Mikdashi, J. A., Esdaile, J. M., Alarcón, G. S., Crofford, L., Fessler, B. J., Shanberg, L., Brunner, H., Gall, V., Kalden, J. R., Lockshin, M. D., Liang, M. H., Roberts, N., Jr., & Schneider, M. (2007). Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus, 16(6), 418–425. https://doi.org/10.1177/0961203307079044
Monahan, R. C., Middelkoop, H. A. M., Beaart-van de Voorde, L. J. J., Fronczek, R., Groenwold, R. H. H., Kloppenburg, M., Huizinga, T. W. J., & Steup-Beekman, G. M. (2023). High prevalence but low impact of cognitive dysfunction on quality of life in patients with lupus and neuropsychiatric symptoms. Arthritis care y research, 75(5), 1017–1025. https://doi.org/10.1002/acr.24904
Morand, E. F., Fernandez-Ruiz, R., Blazer, A., & Niewold, T. B. (2023). Advances in the management of systemic lupus erythematosus. BMJ (Clinical research ed.), 383, e073980. https://doi.org/10.1136/bmj-2022-073980
Munguía-Realpozo, P., García-Carrasco, M., Mendoza-Pinto, C., Galaviz-Silva, M. L., Etchegaray-Morales, I., Méndez-Martínez, S., Montiel-Jarquín, Á. J., Vázquez de Lara, L. G., & Silveira, L. H. (2022). Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosus. Clinical Rheumatology, 41(9), 2737–2743. https://doi.org/10.1007/s10067-022-06215-x
Nantes, S. G., Su, J., Dhaliwal, A., Colosimo, K., & Touma, Z. (2017). Performance of screening tests for cognitive impairment in systemic lupus erythematosus. The Journal of Rheumatology, 44(11), 1583–1589. https://doi.org/10.3899/jrheum.161125
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Ostrosky, F., Lozano, A., Gonzales, G., Manjarrez, D., Torres, M., Gonzalez, J. Luján, A., Janeth, A., Perez, M., & Trejo, D. (2024) Detección del deterioro cognitivo leve con la batería neuropsicológica computarizada de tamizaje. Edupsykhé. Revista De Psicología Y Educación, 21(2), 16-30. https://doi.org/10.57087/edupsykhe.v21i2.4779
Paez-Venegas, N., Jordan-Estrada, B., Chavarria-Avila, E., Perez-Vazquez, F., Gómez-Bañuelos, E., Medina-Dávalos, R., Ontiveros-González, J. Á., Diaz-Rubio, G. I., Navarro-Hernandez, R. E., & Vázquez-Del Mercado, M. (2019). The Montreal cognitive assessment test: A useful tool in screening of cognitive impairment in patients with systemic lupus erythematosus. Journal of Clinical Rheumatology: Practical Reports on Rheumatic y Musculoskeletal Diseases, 25(8), 325–328. https://doi.org/10.1097/RHU.0000000000000876
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.), 372, n71. https://doi.org/10.1136/bmj.n71
Pamfil, C., Fanouriakis, A., Damian, L., Rinzis, M., Sidiropoulos, P., Tsivgoulis, G., Rednic, S., Bertsias, G., & Boumpas, D. T. (2015). EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology (Oxford, England), 54(7), 1270–1278. https://doi.org/10.1093/rheumatology/keu482
Pankowski, D., Wytrychiewicz-Pankowska, K., Pisula, E., & Fal, A. M. (2025). Prevalence of neurocognitive impairment in patients with rheumatoid arthritis a systematic review and meta-analysis. The Clinical Neuropsychologist, 39(2), 252–272. https://doi.org/10.1080/13854046.2024.2378521
Papastefanakis, E., Dimitraki, G., Ktistaki, G., Fanouriakis, A., Karamaouna, P., Bardos, A., Kallitsakis, I., Adamichou, C., Gergianaki, I., Repa, A., Bertsias, G., Sidiropoulos, P., Karademas, E., & Simos, P. (2021). Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample. Lupus, 30(14), 2237–2247. https://doi.org/10.1177/09612033211061062
Pedraza, O., Salazar, A., Sierra, F., Soler, D., Castro, J., Castillo, P., Hernández, A., & Piñeros, C. (2016). Confiabilidad, validez de criterio y discriminante del Montreal Cognitive Assessment (MoCA) test, en un grupo de adultos de Bogotá. Acta Médica Colombiana, 41 (1), 221-228. https://repositorio.fucsalud.edu.co/handle/001/1448
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Kokmen, E., & Tangelos, E. G. (1997). Aging, memory, and mild cognitive impairment. International Psychogeriatrics, 9 Suppl 1, 65–69. https://doi.org/10.1017/s1041610297004717
Pike, N. A., Poulsen, M. K., & Woo, M. A. (2017). Validity of the Montreal cognitive assessment screener in adolescents and young adults with and without congenital heart disease. Nursing Research, 66(3), 222–230. https://doi.org/10.1097/NNR.0000000000000192
Plantinga, L., Yazdany, J., Bowling, C. B., Dunlop-Thomas, C., Hoge, C., Pearce, B. D., Lim, S. S., & Katz, P. (2024). Comparison of cognitive performance measures in individuals with systemic lupus erythematosus. Lupus Science y Medicine, 11(1), e001151. https://doi.org/10.1136/lupus-2024-001151
Raghunath, S., Glikmann-Johnston, Y., Morand, E., Stout, J. C., & Hoi, A. (2021). Evaluation of the Montreal cognitive assessment as a screening tool for cognitive dysfunction in SLE. Lupus Science y Medicine, 8(1), e000580. https://doi.org/10.1136/lupus-2021-000580
Rayes, H. A., Tani, C., Kwan, A., Marzouk, S., Colosimo, K., Medina-Rosas, J., Mustafa, A., Su, J., Lambiris, P., Mosca, M., & Touma, Z. (2018). What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 48(2), 240–255. https://doi.org/10.1016/j.semarthrit.2018.02.007
Reeves, D.L., Kane, R., & Winter, K. (1996). ANAM V3.11a / 96 User's Manual: Clinical and neurotoxicology subsets (Scienti®c Report NCRF-SR-96- 01). San Diego, CA: National Cognitive Recovery Foundation.
Restrepo, G., Calvachi-Gálvez, L., Cano-Álvarez, I. C., & Ruiz-Márquez, A. L. (2019). Las funciones ejecutivas y la lectura: Revisión sistemática de la literatura. Informes Psicológicos, 19(2), 81-94. https://doi.org/10.18566/infpsic.v19n2a06
Roebuck-Spencer, T. M., Yarboro, C., Nowak, M., Takada, K., Jacobs, G., Lapteva, L., Weickert, T., Volpe, B., Diamond, B., Illei, G., & Bleiberg, J. (2006). Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 55(3), 434–441. https://doi.org/10.1002/art.21992
Rosca, E. C., Cornea, A., & Simu, M. (2020). Montreal cognitive assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review. General Hospital Psychiatry, 65, 64–73. https://doi.org/10.1016/j.genhosppsych.2020.05.011
Rubio, M. (2021) Frecuencia, tipo y determinantes de déficit cognitivo en una cohorte colombiana de pacientes con lupus eritematoso sistémico. Departamento de Medicina interna Especialidad Reumatología. Universidad Nacional de Colombia. https://repositorio.unal.edu.co/bitstream/handle/unal/80066/1036617596.2021.pdf?sequence=2yisAllowed=y
Stavrogianni, K., Kitsos, D. K., Giannopapas, V., Chasiotis, A. K., Christouli, N., Paraskevas, P. G., Zompola, C., Tsivgoulis, G., Paraskevas, G. P., & Giannopoulos, S. (2024). Neuropsychological profiles comparison between Multiple Sclerosis patients and Multiple Sclerosis patients with overlapping features of Systemic Lupus Erythematosus. Journal of Neuroimmunology, 387, 578270. https://doi.org/10.1016/j.jneuroim.2023.578270
Smitherman, E. A., Chahine, R. A., Beukelman, T., Lewandowski, L. B., Rahman, A. K. M. F., Wenderfer, S. E., Curtis, J. R., Hersh, A. O., & CARRA Registry Investigators (2023). Childhood-onset lupus nephritis in the childhood arthritis and rheumatology research alliance registry: short-term kidney status and variation in care. Arthritis Care y Research, 75(7), 1553–1562. https://doi.org/10.1002/acr.25002
Suntoko, B., Hadisaputro, S., Kalim, H., Hadi, S., & Saputra, W. A. (2023). Relationship between disease activity, levels of IFN-a, IL-4, IL-6, and Anti-NMDA to cognitive dysfunction (MoCA-INA Score) in systemic lupus erythematosus (SLE) patients with cognitive dysfunction. Acta Medica Indonesiana, 55(3), 307–314. https://www.actamedindones.org/index.php/ijim/article/view/2475/pdf
Tayer-Shifman, O. E., Green, R., Beaton, D. E., Ruttan, L., Wither, J. E., Tartaglia, M. C., Kakvan, M., Lombardi, S., Anderson, N., Su, J., Bonilla, D., Zandy, M., Choi, M. Y., Fritzler, M. J., & Touma, Z. (2019). Validity evidence for the use of automated neuropsychologic assessment metrics as a screening tool for cognitive impairment in systemic lupus erythematosus. Arthritis Care y Research, 72(12), 1809–1819. https://doi.org/10.1002/acr.24096
Tayer-Shifman, O. E., Yuen, K., Green, R., Kakvan, M., Katz, P., Bingham, K. S., Diaz-Martinez, J. P., Ruttan, L., Wither, J. E., Tartaglia, M. C., Su, J., Bonilla, D., Choi, M. Y., Appenzeller, S., Barraclough, M., Beaton, D. E., & Touma, Z. (2023). Assessing the utility of the montreal cognitive assessment in screening for cognitive impairment in patients with systemic lupus erythematosus. Arthritis Care y Research, 75(3), 569–577. https://doi.org/10.1002/acr.24971
Torralva, T., Roca, M., Gleichgerrcht, E., López, P., & Manes, F. (2009). INECO frontal screening (IFS): A brief, sensitive, and specific tool to assess executive functions in dementia. Journal of the International Neuropsychological Society, 15(5), 777-786. https://doi.org/10.1017/S1355617709990415
Valdés Cabrera, D., El Tal, T., Mohamed, I., Arciniegas, S. E., Fevrier, S., Ledochowski, J., & Knight, A. M. (2024). Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction. Lupus Science y Medicine, 11(2), e001214. https://doi.org/10.1136/lupus-2024-001214
Vinet, E., Rodríguez-Cancino, M., Sandoval Domínguez, A., Rojas Mora, P., & Saiz, J. L. (2023). El empleo de test por psicólogos/as Chilenos/as: Un inquietante panorama. Psykhe (Santiago), 32(1), 00109. https://doi.org/10.7764/psykhe.2020.25293
Willame, C., Dodd, C., van der Aa, L., Picelli, G., Emborg, H.-D., Kahlert, J., Gini, R., Huerta, C., Martìn-Merino, E., McGee, C., de Lusignan, S., Roberto, G., Villa, M., Weibel, D., Titievsky, L., & Sturkenboom, M. C. J. M. (2021). Incidence rates of autoimmune diseases in european healthcare databases: A contribution of the ADVANCE project. Drug Safety, 44(3), 383 -395. https://doi.org/10.1007/s40264-020-01031-1
Wang, X., Li, F., Gao, Q., Jiang, Z., Abudusaimaiti, X., Yao, J., & Zhu, H. (2022). Evaluation of the accuracy of cognitive screening tests in detecting dementia associated with alzheimer's disease: A hierarchical bayesian latent class meta-analysis. Journal of Alzheimer's Disease: JAD, 87(1), 285–304. https://doi.org/10.3233/JAD-215394
Wang, L., Zheng, G., Jia, X., Zhang, X., & Chen, Y. (2023). Application study of brain structure and functional magnetic resonance imaging in patients with systemic lupus erythematosus and cognitive dysfunction. Alternative Therapies in Health and Medicine, 29(8), 60–65. http://alternative-therapies.com/oa/index.html?fid=9171
Wei, X., Ma, Y., Wu, T., Yang, Y., Yuan, Y., Qin, J., Bu, Z., Yan, F., Zhang, Z., & Han, L. (2023). Which cutoff value of the Montreal Cognitive Assessment should be used for post-stroke cognitive impairment? A systematic review and meta-analysis on diagnostic test accuracy.International Journal of Stroke: Official Journal of the International Stroke Society, 18(8), 908–916. https://doi.org/10.1177/17474930231178660
Yang, Y., Zhao, R., Zhang, F., Bai, R., Li, S., Cui, R., Liu, S., & Xu, J. (2022). Dynamic changes of amplitude of low-frequency in systemic lupus erythematosus patients with cognitive impairment. Frontiers in Neuroscience, 16, 929383. https://doi.org/10.3389/fnins.2022.929383
Yue, R., Gurung, I., Long, X. X., Xian, J. Y., & Peng, X. B. (2020). Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus. Lupus, 29(13), 1743–1751. https://doi.org/10.1177/096120332095806
Yuen, K., Kakvan, M., Tayer-Shifman, O. E., Rozenbojm, N., Bingham, K., & Touma, Z. (2021a). Assessment of cognitive function in systemic lupus erythematosus. In: Touma, Z. (eds) Outcome Measures and Metrics in Systemic Lupus Erythematosus. Springer, Cham. https://doi.org/10.1007/978-3-030-73303-2_13
Yuen, K., Green, R., Bingham, K., Ruttan, L., Lee-Kim, V., Tartaglia, M. C., Anderson, M., Zandy, M., Choi, M. Y., Fritzler, M. J., Wither, J. E., Beaton, D. E., Katz, P., & Touma, Z. (2021b). Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review. Seminars in Arthritis and Rheumatism, 51(4), 819–830. https://doi.org/10.1016/j.semarthrit.2021.05.018
Zabala, A., Salgueiro, M., Sáez-Atxukarro, O., Ballesteros, J., Ruiz-Irastorza, G., & Segarra, R. (2018). Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis. Journal of the International Neuropsychological Society: JINS, 24(6), 629–639. https://doi.org/10.1017/S1355617718000073
Downloads
Published
Issue
Section
License
Articles and conference papers published in Mediterranean Journal of Clinical Psychology are distributed under the terms and conditions of a Creative Commons Attribution 4.0 Unported License. Correspondingly, authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
